ArticleInternal medicine (Tokyo, Japan)2022

Pasireotide-resistant Refractory Cushing's Disease without Somatostatin Receptor 5 Expression.

Tomoko Mizuno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.